The world's first vaccine against dengue, developed by French drugmaker Sanofi, has shown the ability to protect against disease caused by three of four dengue virus strains in a keenly awaited clinical trial in Thailand.
Sanofi said on Wednesday the proof of efficacy was "a key milestone" in the 70-year quest to develop a viable dengue shot, adding the results also confirmed the safety profile of the vaccine candidate.
The mosquito-borne disease - also known as "breakbone fever" - is a threat to nearly 3 billion people and is caused by four different types of virus, none of which confers immunity from the others.
Sanofi's vaccine generated an antibody response for all four dengue virus types, but evidence of protection was only demonstrated against three of the four circulating in Thailand. Sanofi said researchers were carrying out analyses to understand the lack of protection for the fourth serotype.
The company's vaccine unit, Sanofi Pasteur, has already invested 350 million euros ($423 million) in a new French factory to make the three-dose vaccine and believes its product could generate 1 billion euros in yearly sales.
But uptake of the vaccine will depend on precisely how well doctors believe it can protect populations at risk in fast-expanding tropical cities from Rio to Manila, as well as travelers.
Sanofi gave no details on the level of protection in a brief statement. The full data are now being reviewed by scientific experts and public health officials, with detailed results to be published later this year.
Sanofi previously said it planned to present the findings at the annual meeting of the American Society of Tropical Medicine and Hygiene in Atlanta in November.
Large-scale late-stage Phase III clinical studies with 31,000 participants are under way with Sanofi's vaccine in 10 countries in Asia and Latin America.
An MSF report found that malaria cases in Bossangoa had more than tripled to 6,507 in May with almost two-thirds of those children under the age of five.
If confirmed, the case would be the first on record of one of the world's deadliest diseases in Nigeria, Africa's biggest economy and, with 170 million people, its most populous country.
Researchers said the findings challenge the universal endorsement of paracetamol as the first choice painkiller for lower back pain.
The 39-year-old Sheik Umar Khan, hailed as a "national hero" by the health ministry, was leading the fight to control an outbreak that has killed 206 people in the West African country
Shanghai food watchdog said it sealed more than 1,000 tonnes of suspected meat products from OSI in China, and a further 100 tonnes of products from a range of its customers.
Children in Syria are at greatest risk as routine immunisation has been disrupted and many health centres are severely damaged after more than three years of conflict
151 people who came into direct contact with the victim were also placed in quarantine.
Viruses that spread through air - such as flu viruses for example - are far more likely to spread swiftly and widely in human populations
TV report that showed workers picking up meat from a factory floor, as well as mixing meat beyond its expiration date with fresh meat
Religious leaders to preach in their churches and mosques for a change of attitude towards the disease
The three people in the latest reported cases had "mild symptoms" and have fully recovered after being treated with antibiotics, the department said, adding that they are no longer contagious.
A state landmark, Mount Rainier last erupted in the 19th century. It is widely expected to erupt again, according to the U.S. National Park Service.
The new vaccine will help save the lives of hundreds of thousands of South Sudanese children.
Food security became a hot topic after record high grain prices in 2008 marked the start of a period of volatility.
An agreement by the court with the advocate general's opinion would have significant repercussions on employers as they could be required to make special adjustments for morbidly obese employees
Steroid-containing inhalers' potential effect on children's growth is a source of worry for parents and doctors